Familial LCAT deficiency: from renal replacement to enzyme replacement

R. M. Stoekenbroek, M. A. van den Bergh Weerman, G. K. Hovingh, B. J. Potter van Loon, C. E. H. Siegert, A. G. Holleboom

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)

Abstract

Familial LCAT deficiency (FLD) is a recessive lipid disorder ultimately leading to end-stage renal disease (ESRD). We present two brothers with considerable variation in the age at which they developed ESRD. Kidney biopsies revealed both tubular and glomerular pathology. To date, no causal therapy is available, yet enzyme replacement therapy is in development
Original languageEnglish
Pages (from-to)29-31
JournalNetherlands journal of medicine
Volume71
Issue number1
Publication statusPublished - 2013

Cite this